The findings indicated no statistically significant difference in BSAP levels between the T2DM group and the control group (SMD = 0.14, 95% CI = −0.25 to 0.53, p = 0.047, Figure 4). This evidence concerns the gene PAX5 and type 2 diabetes mellitus.